234 related articles for article (PubMed ID: 31694244)
1. Development and Evaluation of Physiologically Based Pharmacokinetic Drug-Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations.
Rasool MF; Khalid S; Majeed A; Saeed H; Imran I; Mohany M; Al-Rejaie SS; Alqahtani F
Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31694244
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Role of Altered Systemic Albumin Concentration on the Disposition of Theophylline in Adult and Pediatric Patients with Asthma by Using the Physiologically Based Pharmacokinetic Approach.
Rasool MF; Khalid R; Imran I; Majeed A; Saeed H; Alasmari F; Alanazi MM; Alqahtani F
Drug Metab Dispos; 2020 Jul; 48(7):570-579. PubMed ID: 32393652
[TBL] [Abstract][Full Text] [Related]
3. Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach.
Rasool MF; Khalil F; Läer S
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):383-396. PubMed ID: 27313074
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of a Physiologically Based Pharmacokinetic Drug-Disease Model of Propranolol for Suggesting Model Informed Dosing in Liver Cirrhosis Patients.
Kalam MN; Rasool MF; Alqahtani F; Imran I; Rehman AU; Ahmed N
Drug Des Devel Ther; 2021; 15():1195-1211. PubMed ID: 33762817
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases.
Rasool MF; Ali S; Khalid S; Khalid R; Majeed A; Imran I; Saeed H; Usman M; Ali M; Alali AS; AlAsmari AF; Ali N; Asiri AM; Alasmari F; Alqahtani F
Sci Rep; 2021 Apr; 11(1):8589. PubMed ID: 33883647
[TBL] [Abstract][Full Text] [Related]
6. A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications.
Khalid S; Rasool MF; Imran I; Majeed A; Saeed H; Rehman AU; Ashraf W; Ahmad T; Bin Jardan YA; Alqahtani F
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575556
[TBL] [Abstract][Full Text] [Related]
7. Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Predicting Haloperidol Exposure in Healthy and Disease Populations.
Alasmari MS; Alasmari F; Alasmari AF; Alshamsan A; Alsanea S; Rasool MF; Alqahtani F
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145543
[TBL] [Abstract][Full Text] [Related]
8. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
Rasool MF; Khalil F; Läer S
Clin Pharmacokinet; 2015 Sep; 54(9):943-62. PubMed ID: 25773479
[TBL] [Abstract][Full Text] [Related]
9. A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations.
Talha Zahid M; Zamir A; Majeed A; Imran I; Alsanea S; Ahmad T; Alqahtani F; Fawad Rasool M
Saudi Pharm J; 2023 Aug; 31(8):101675. PubMed ID: 37576858
[TBL] [Abstract][Full Text] [Related]
10. Predicting Hydroxychloroquine Clearance in Healthy and Diseased Populations Using a Physiologically Based Pharmacokinetic Approach.
Alqahtani F; Asiri AM; Zamir A; Rasool MF; Alali AS; Alsanea S; Walbi IA
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111735
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Utility of Physiologically-based Pharmacokinetic Model for prediction of Pharmacokinetics in Chinese and Japanese Populations.
Yu Y; Lin J; Muto C; Li Y; Mori Y; Mittapalli RK; Tse S; Liu J; Ge BK; Liu J
Int J Med Sci; 2021; 18(16):3718-3727. PubMed ID: 34790045
[TBL] [Abstract][Full Text] [Related]
12. Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
Khalil F; Läer S
AAPS J; 2014 Mar; 16(2):226-39. PubMed ID: 24399240
[TBL] [Abstract][Full Text] [Related]
13. In silico evaluation of gadofosveset pharmacokinetics in different population groups using the Simcyp® simulator platform.
Spanakis M; Marias K
In Silico Pharmacol; 2014 Dec; 2(1):2. PubMed ID: 27502621
[TBL] [Abstract][Full Text] [Related]
14. Application of a physiologically based pharmacokinetic model in predicting captopril disposition in children with chronic kidney disease.
Khalid S; Rasool MF; Masood I; Imran I; Saeed H; Ahmad T; Alqahtani NS; Alshammari FA; Alqahtani F
Sci Rep; 2023 Feb; 13(1):2697. PubMed ID: 36792681
[TBL] [Abstract][Full Text] [Related]
15. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
Yun YE; Edginton AN
J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
[TBL] [Abstract][Full Text] [Related]
16. Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example.
Chen Y; Zhu R; Ma F; Mao J; Chen EC; Choo EF; Sahasranaman S; Liu L
Biopharm Drug Dispos; 2018 Nov; 39(9):420-430. PubMed ID: 30335192
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia.
Kalsoom S; Rasool MF; Imran I; Saeed H; Ahmad T; Alqahtani F
Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399480
[TBL] [Abstract][Full Text] [Related]
18. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen.
Loisios-Konstantinidis I; Cristofoletti R; Jamei M; Turner D; Dressman J
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33147873
[TBL] [Abstract][Full Text] [Related]
19. Physiologically Based Pharmacokinetic Model To Predict Metoprolol Disposition in Healthy and Disease Populations.
Zamir A; Rasool MF; Imran I; Saeed H; Khalid S; Majeed A; Rehman AU; Ahmad T; Alasmari F; Alqahtani F
ACS Omega; 2023 Aug; 8(32):29302-29313. PubMed ID: 37599939
[TBL] [Abstract][Full Text] [Related]
20. Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application.
Ngampanya A; Udomnilobol U; Sermsappasuk P; Pornputtapong N; Ongpipattanakul B; Patel N; Jianmongkol S; Prueksaritanont T
J Pharm Sci; 2021 May; 110(5):2301-2310. PubMed ID: 33609522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]